RxDoctor Payments Data

Ajul Shah, MD

Surgery of the Hand · Pennington, NJNPI 1598085961

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $63,895 of the $103,860 with a category attached, or 61.5%. 30 manufacturers reported payments, led by Integra Lifesciences Corporation at 51.3% of the total. Reporting peaked in 2023 at $25,056 and has fallen 78.8% since, to $5,313 in 2025.

$103,860in general payments, 2019–2025

Across 169 payments — averaging $614.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$53K
  • Baxter Healthcare$37K
  • Checkpoint Surgical, Inc$11K
  • Bioventus LLC$271
  • Skeletal Dynamics Inc$225
  • Johnson & Johnson$220
  • plus $2K from 24 others

What the payments were for

  • Consulting fees$63,89562%
  • Speaking & faculty fees$28,69728%
  • Travel & lodging$6,6336%
  • Food & beverage$4,4564%
  • Other$1790%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few surgery of the hand providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$55,924
Medicare patients
122
Services billed
481

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin35$543
Ibuprofen28$131

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Pennington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →